Difficulty: Medium
Average Score: 70%
Practice
A 70-year-old man presents to clinic because of low-grade fever for the past 2 weeks. He otherwise feels well. On exam, the physician is able to palpate an enlarged spleen. A complete blood count shows a WBC count of 43,000/ÃśÂ¼L. A peripheral blood smear confirms the diagnosis of chronic myelogenous leukemia. Chromosomal studies are positive for the Philadelphia chromosome. What is the mechanism of action of the medication given to halt the progression of the disease?
Correct answer
D
Rationale
Imatinib, used for CML with Philadelphia chromosome (BCR-ABL fusion), is a tyrosine kinase inhibitor, blocking the aberrant kinase activity driving leukemic cell proliferation.